Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,223 INR | -0.37% | -12.89% | +17.70% |
May. 14 | Transcript : Neuland Laboratories Limited, Q4 2024 Earnings Call, May 14, 2024 | |
May. 10 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
Sales 2024 | 15.59B 187M | Sales 2025 * | 15.98B 191M | Capitalization | 80.14B 960M |
---|---|---|---|---|---|
Net income 2024 | 3B 35.96M | Net income 2025 * | 3.02B 36.15M | EV / Sales 2024 | 5.17 x |
Net cash position 2024 * | 2.32B 27.86M | Net cash position 2025 * | 3.57B 42.76M | EV / Sales 2025 * | 4.79 x |
P/E ratio 2024 |
26.9
x | P/E ratio 2025 * |
26.7
x | Employees | 1,554 |
Yield 2024 * |
0.19% | Yield 2025 * |
0.15% | Free-Float | 62.32% |
Latest transcript on Neuland Laboratories Limited
1 day | -0.37% | ||
1 week | -12.89% | ||
Current month | -18.12% | ||
1 month | -17.24% | ||
3 months | -12.96% | ||
6 months | +17.74% | ||
Current year | +17.70% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 01-12-31 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 22-11-22 |
Chief Tech/Sci/R&D Officer | - | Nov. 21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 22-10-30 | |
Director/Board Member | 80 | 19-02-11 | |
Sugata Sircar
BRD | Director/Board Member | 60 | 23-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 6,223 | -0.37% | 2 937 |
24-05-15 | 6,246 | +1.30% | 2,713 |
24-05-14 | 6,166 | +1.78% | 3,358 |
24-05-13 | 6,058 | -15.08% | 12,122 |
24-05-10 | 7,134 | -0.14% | 972 |
Delayed Quote Bombay S.E., May 16, 2024 at 06:00 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.70% | 960M | |
+35.01% | 709B | |
+30.48% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.49% | 239B | |
+9.39% | 211B | |
-3.64% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- NEULANDLAB Stock